| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From Deutsches Herzzentrum, Berlin, Germany.
Correspondence to: Ralf Ewert, MD, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
Objective: To investigate the long-term development of pulmonary diffusion abnormalities after orthotopic heart transplantation (oHT).
Design: Retrospective analysis of pulmonary function test results of different patient groups at different time intervals after oHT was performed.
Patients: This investigation included 642 patients who had undergone oHT for chronic heart failure. Patients were grouped according to the time elapsed after transplantation (group 1: n = 164; age, 47 ± 14 years; days after oHT, 324 ± 101; group 2: n = 100; age, 48 ± 15 years; days after oHT, 723 ± 104; group 3: n = 106; age, 52 ± 12 years; days after oHT, 1,092 ± 98; group 4: n = 84; age, 51 ± 13 years; days after oHT, 1,442 ± 99; group 5: n = 61; age, 50 ± 14 years; days after oHT, 1,819 ± 105; group 6: n = 101; age, 53 ± 12 years; days after oHT, 2,463 ± 303; and group 7: n = 26; age, 54 ± 14 years; days after oHT, 3,478 ± 246). In 56 (group 8) of the 642 patients, follow-up measurements were performed with tests before and at two time points after oHT (6.5 ± 1.7 and 12.5 ± 9.3 months).
Results: Of all patients, 39% showed restrictive and obstructive abnormalities with no differences between the groups. No significant differences in lung transfer factor for carbon monoxide (DLCO) were observed (61.2 vs 63.7 vs 65.5 vs 65.6 vs 64.5 vs 65.7 vs 67.6% predicted). Differences in transfer coefficient for carbon monoxide (KCO) were significant between group 1 and 4 (58.7 vs 64.1% predicted), and group 1 and 6 (58.7 vs 63.4% predicted). No differences occurred in the rate with which patients exhibited pathologic abnormalities for DLCO and KCO. After oHT, a marked reduction in diffusion capacity occurred in group 8. On follow-up, these measurements were only slightly restored in terms of the predicted DLCO percentage. No such improvement was observed in KCO or in the rate of pathologic changes for both DLCO and KCO. We conclude, therefore, that the impairment of diffusion does not improve even after a significant period has passed after the oHT. Whether this has any effect on symptoms and/or the prognosis for these patients is extremely unclear.
Key Words: chronic heart failure • diffusion capacity • heart transplantation • long-term follow-up • pulmonary function test
This article has been cited by other articles:
|
|
 |
|
  M. Quantz, S. Wilson, C. Smith, L. Stitt, R. Novick, and D. Ahmad Advantages of the Intrabreath Technique as a Measure of Lung Function Before and After Heart Transplantation Chest, November 1, 2003; 124(5): 1658 - 1662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Guazzi Alveolar-Capillary Membrane Dysfunction in Heart Failure: Evidence of a Pathophysiologic Role Chest, September 1, 2003; 124(3): 1090 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Schaufelberger Pulmonary diffusion capacity as prognostic marker in chronic heart failure Eur. Heart J., March 2, 2002; 23(6): 429 - 431. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Guazzi, P. Agostoni, and M. D. Guazzi Modulation of alveolar-capillary sodium handling as a mechanism of protection of gas transfer by enalapril, and not by losartan, in chronic heart failure J. Am. Coll. Cardiol., February 1, 2001; 37(2): 398 - 406. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ewert, R. Wensel, L. Bruch, S. Mutze, U. Bauer, M. Plauth, and F.-X. Kleber Relationship Between Impaired Pulmonary Diffusion and Cardiopulmonary Exercise Capacity After Heart Transplantation Chest, April 1, 2000; 117(4): 968 - 975. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
